Study of GS-1811 Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors

Recruiting

Phase 1

GS-1811 & ZimberelimabStudy of GS-1811 Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors

Sponsor:

Gilead Sciences

Code:

NCT05007782

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Denikitug

Zimberelimab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Gilead Sciences on 2024-12-20.